Albert Bourla, CEO of Pfizer, joins 'Money Movers' to discuss drug pricing, the impact on artificial intelligence on ...

U.S. pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to ...

According to reporting from Bloomberg at the J.P. Morgan Healthcare Conference that ended today in San Francisco, ...

US pharma giants seek to dodge Trump’s campaign to lower drug costs . American pharmaceutical corporations are reportedly ...

Pharmaceutical companies seek to make up lost revenue after striking deals with Donald Trump to lower costs in US ...

Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent ...

David Ricks, CEO of the Indiana drugmaker, has cut deals with the president to slash prices and build American. Trump has ...

Pfizer remains a Strong Buy, with oncology breakthroughs, a revitalized obesity pipeline, and aggressive cost savings ...

Speaking before a darkened ballroom, US Chamber of Commerce CEO Suzanne Clark called on executives to be “fearless” in defence of free markets over government control and ...

Drugmaker CEOs see online sales channels as a budding opportunity, while some biotech investors told BioPharma Dive to expect a rebound in new stock offerings.

Pfizer CEO Albert Bourla ​had ‌also said he was "seriously frustrated" with ‍the administration's stance ⁠on vaccines, as ...